oncology
Biomarker To Help Improve Lung Cancer Treatment Identified
Posted in Medicine on 16th Aug, 2023
by Alex Muller
By sorting lung tumours according to specific EGFR mutations, it might be possible to create a more personalized drug protocol and achieve better results.
Japan's Daiichi Sankyo gets US FDA nod for blood cancer treatment
Posted in Medicine on 21st Jul, 2023
by Alex Muller
AML is one of the most common types of blood cancer in adults. Mutations in the FLT3 gene, which plays a role in helping white blood cells grow, can cause excess growth of these cells and lead to an aggressive form of leukemia.
FDA grants fast track designation to myelofibrosis, nasopharyngeal cancer therapies
Posted in Medicine on 21st Jul, 2023
by Alex Muller
The FDA granted fast track designation to two oncology therapies.
Liquid biopsy may aid in diagnosis, surveillance of HPV-associated oropharyngeal cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
Tumor tissue-modified viral-HPV DNA demonstrated 91.5% sensitivity among patients in the diagnostic cohort and 88.4% in the surveillance cohort.
Tislelizumab Plus Bevacizumab/Chemo Demonstrates Early Efficacy in Cervical Cancer
Posted in Medicine on 20th Jul, 2023
by Alex Muller
The addition of the PD-L1 inhibitor tislelizumab to standard bevacizumab and platinum-doublet chemotherapy in the first-line setting prolonged progression-free survival, produced encouraging responses, and was well tolerated in patients with cervical cancer.